Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Medicinas Tradicionales
Métodos Terapéuticos y Terapias MTCI
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rev. bras. ginecol. obstet ; 44(11): 1059-1069, Nov. 2022. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1423269

RESUMEN

Abstract Objective The aim of this study was to systematically review literature on the use of iron supplements (not including iron derived from diet), increased levels of hemoglobin and/or ferritin, and the risk of developing gestational diabetes mellitus (GDM). Data source The following databases were searched, from the study's inception to April 2021: PUBMED, Cochrane, Web of Science, Scopus, Embase, Cinahl and Lilacs. Selection of studies A total of 6,956 titles and abstracts were reviewed, 9 of which met the final inclusion criteria, with 7,560 women in total. Data collection Data extraction was performed by two independent reviewers and disagreements were resolved by a third researcher. Data synthesis Methodological quality in controlled trials were assessed according to the Cochrane Collaboration tools (ROB-2 and ROBINS-1) and for the observational studies, the National Institutes of Health's (NIH) quality assessment tool was used. Among the 5 observational studies, women with a higher hemoglobin or ferritin level were more likely to develop GDM when compared with those with lower levels of these parameters. Among the 3 randomized clinical trials, none found a significant difference in the incidence of GDM among women in the intervention and control groups. However, we identified many risks of bias and great methodological differences among them. Conclusion Based on the studies included in this review, and due to the important methodological problems pointed out, more studies of good methodological quality are needed to better establish the association between iron supplementation and GDM.


Resumo Objetivo O objetivo deste estudo foi revisar sistematicamente a literatura sobre o uso de suplementos de ferro (não incluindo o ferro derivado da dieta), aumento dos níveis de hemoglobina e/ou ferritina e o risco de desenvolver diabetes mellitus gestacional (DMG). Fontes dos dados as bases de dados PUBMED, Cochrane, Web of Science, Scopus, Embase, Cinahl e Lilacs foram pesquisadas até abril de 2021. Seleção dos estudos Foram revisados 6.956 títulos e resumos, dos quais 9 preencheram os critérios finais de inclusão, totalizando 7.560 mulheres. Coleta de dados A extração de dados foi realizada por dois revisores independentes e as divergências foram resolvidas por um terceiro revisor. Síntese dos dados A qualidade metodológica dos ensaios controlados foi avaliada de acordo com as ferramentas da Colaboração Cochrane (ROB-2 e ROBINS-1) e para os estudos observacionais, foi utilizada a ferramenta de avaliação de qualidade do National Institutes of Health (NIH). Entre os 5 estudos observacionais, as mulheres com maiores níveis de hemoglobina ou ferritina apresentaram maior probabilidade de desenvolver DMG quando comparadas àquelas com níveis mais baixos nesses parâmetros. Entre os 3 ensaios clínicos randomizados, nenhum deles encontrou diferença significativa na incidência de DMG entre as mulheres dos grupos de intervenção e controle. No entanto, identificamos muitos riscos de viés e enormes diferenças metodológicas entre eles. Conclusão Com base nos estudos incluídos nesta revisão e devido aos importantes problemas metodológicos apontados, são necessários mais estudos de boa qualidade metodológica para melhor estabelecer a associação entre suplementação de ferro e DMG.


Asunto(s)
Humanos , Femenino , Embarazo , Hemoglobinas , Diabetes Gestacional , Ferritinas , Deficiencias de Hierro
2.
Rev Bras Ginecol Obstet ; 44(11): 1059-1069, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36067799

RESUMEN

OBJECTIVE: The aim of this study was to systematically review literature on the use of iron supplements (not including iron derived from diet), increased levels of hemoglobin and/or ferritin, and the risk of developing gestational diabetes mellitus (GDM). DATA SOURCE: The following databases were searched, from the study's inception to April 2021: PUBMED, Cochrane, Web of Science, Scopus, Embase, Cinahl and Lilacs. SELECTION OF STUDIES: A total of 6,956 titles and abstracts were reviewed, 9 of which met the final inclusion criteria, with 7,560 women in total. DATA COLLECTION: Data extraction was performed by two independent reviewers and disagreements were resolved by a third researcher. DATA SYNTHESIS: Methodological quality in controlled trials were assessed according to the Cochrane Collaboration tools (ROB-2 and ROBINS-1) and for the observational studies, the National Institutes of Health's (NIH) quality assessment tool was used. Among the 5 observational studies, women with a higher hemoglobin or ferritin level were more likely to develop GDM when compared with those with lower levels of these parameters. Among the 3 randomized clinical trials, none found a significant difference in the incidence of GDM among women in the intervention and control groups. However, we identified many risks of bias and great methodological differences among them. CONCLUSION: Based on the studies included in this review, and due to the important methodological problems pointed out, more studies of good methodological quality are needed to better establish the association between iron supplementation and GDM.


OBJETIVO: O objetivo deste estudo foi revisar sistematicamente a literatura sobre o uso de suplementos de ferro (não incluindo o ferro derivado da dieta), aumento dos níveis de hemoglobina e/ou ferritina e o risco de desenvolver diabetes mellitus gestacional (DMG). FONTES DOS DADOS: as bases de dados PUBMED, Cochrane, Web of Science, Scopus, Embase, Cinahl e Lilacs foram pesquisadas até abril de 2021. SELEçãO DOS ESTUDOS: Foram revisados 6.956 títulos e resumos, dos quais 9 preencheram os critérios finais de inclusão, totalizando 7.560 mulheres. COLETA DE DADOS: A extração de dados foi realizada por dois revisores independentes e as divergências foram resolvidas por um terceiro revisor. SíNTESE DOS DADOS: A qualidade metodológica dos ensaios controlados foi avaliada de acordo com as ferramentas da Colaboração Cochrane (ROB-2 e ROBINS-1) e para os estudos observacionais, foi utilizada a ferramenta de avaliação de qualidade do National Institutes of Health (NIH). Entre os 5 estudos observacionais, as mulheres com maiores níveis de hemoglobina ou ferritina apresentaram maior probabilidade de desenvolver DMG quando comparadas àquelas com níveis mais baixos nesses parâmetros. Entre os 3 ensaios clínicos randomizados, nenhum deles encontrou diferença significativa na incidência de DMG entre as mulheres dos grupos de intervenção e controle. No entanto, identificamos muitos riscos de viés e enormes diferenças metodológicas entre eles. CONCLUSãO: Com base nos estudos incluídos nesta revisão e devido aos importantes problemas metodológicos apontados, são necessários mais estudos de boa qualidade metodológica para melhor estabelecer a associação entre suplementação de ferro e DMG.


Asunto(s)
Diabetes Gestacional , Estados Unidos , Embarazo , Femenino , Humanos , Diabetes Gestacional/epidemiología , Ferritinas , Sales (Química) , Hierro , Hemoglobinas
3.
Nursing (Ed. bras., Impr.) ; 24(272): 5108-5114, jan.2021.
Artículo en Portugués | BDENF, LILACS | ID: biblio-1148441

RESUMEN

Objetivo: identificar os conceitos e cuidados de enfermagem relacionados a Lesão Terminal de Kennedy disponíveis na literatura. Método: Trata-se de uma revisão integrativa que utilizou como base de dados BVS e Portal de Periódicos CAPES, usando os referenciais MEDLINE, LILACS, BDENF e SciELO. Foram considerados estudos que avaliavam a Lesão Terminal de Kennedy e cuidados de enfermagem. Resultados: Foram incluídos um total de 05 publicações no formato de textos e resumos completos, sendo 04 estudos e 01 editorial. Os estudos são de língua estrangeira (inglês e espanhol), reforçando assim a alerta para a necessidade da comunidade científica nacional. Os dados foram categorizados, sendo agrupados em duas categorias: Úlcera Terminal de Kennedy e suas peculiaridades e Implementações de Enfermagem no fim da vida. Conclusão: Percebe-se ainda uma escassez nos estudos científicos principalmente pela comunidade científica nacional em particular os enfermeiros demonstrando o déficit de conhecimentos produzidos relacionados ao cuidar de pacientes acometidos pela Lesão Terminal de Kennedy.(AU)


Objective: to identify the nursing concepts and care related to Kennedy's Terminal Injury available in the literature. Method: This is an integrative review that used the BVS and CAPES Journals Portal Database, using the MEDLINE, LILACS, BDENF and SciELO. Studies that evaluated Kennedy's Terminal Injury and nursing care were considered. Results: A total of 05 publications in the form of texts and full abstracts were included, 04 studies and 01 editorial. The studies are in a foreign language (English and Spanish), thus reinforcing the alert to the need of the national scientific community. The data were categorized, being grouped into two categories: Kennedy's Terminal Ulcer and its peculiarities and the strategies of Nursing actions at the end of life. Conclusion: There is still a shortage in scientific studies mainly by the national scientific community, in particular nurses demonstrating the lack of knowledge produced related to caring for patients affected by Kennedy's Terminal Injury.(AU)


Objetivo: identificar los conceptos y cuidados de enfermería relacionados con la Lesión Terminal Kennedy disponibles en la literatura. Método: Se trata de una revisión integradora que utilizó la base de datos del Portal de Revistas de la BVS y CAPES, utilizando las referencias MEDLINE, LILACS, BDENF y SciELO. Se consideraron los estudios que evaluaron la lesión terminal de Kennedy y la atención de enfermería. Resultados: Se incluyeron un total de 05 publicaciones en forma de textos y resúmenes completos, 04 estudios y 01 editorial. Los estudios son en lengua extranjera (inglés y español), reforzando así la alerta a la necesidad de la comunidad científica nacional. Los datos fueron categorizados, agrupándose en dos categorías: Úlcera Terminal Kennedy y sus peculiaridades y las estrategias de actuación de Enfermería al final de la vida. Conclusión: Aún existe una escasez de estudios científicos principalmente de la comunidad científica nacional, en particular enfermeras que demuestren la falta de conocimiento producido relacionado con el cuidado de los pacientes afectados por la Lesión Terminal Kennedy.(AU)


Asunto(s)
Humanos , Cuidados Paliativos , Cuidado Terminal , Úlcera , Heridas y Lesiones , Enfermería de Cuidados Paliativos al Final de la Vida
4.
Nutr Hosp ; 37(6): 1238-1245, 2020 Dec 16.
Artículo en Inglés | MEDLINE | ID: mdl-33155475

RESUMEN

INTRODUCTION: Introduction: vitamin D deficiency (VDD) has been associated with depressive symptoms in pregnancy and postpartum, which can result in increased adverse outcomes in the maternal-infant segment. A possible explanation in the literature is VDD relationship with genetic and neurological mechanisms. Objective: to evaluate VDD relationship with gestational and postpartum depression. Methods: this review followed the recommendations proposed by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis. Research was conducted in electronic databases, PubMed and LILACS, including studies of the analytical type (cross-sectional and longitudinal), systematic reviews, meta-analyses, and controlled clinical trials carried out in humans; inclusion and exclusion criteria were applied. Results and conclusions: in this systematic review, eight articles were analyzed comprising 8,583 women from seven different countries. Among the selected articles, six found an association between VDD and gestational and postpartum depression. Considering the data collection, it was possible to conclude that there is a probable relationship between VDD and a higher predisposition to gestational and postpartum depression. Also, we concluded that vitamin D supplementation has proven to be a promising strategy for reducing the risk of depressive symptoms.


INTRODUCCIÓN: Introducción: la deficiencia de vitamina D (VDD) se ha asociado a síntomas depresivos en el embarazo y el posparto, lo que puede resultar en un aumento de los resultados adversos en el segmento materno-infantil. Una posible explicación en la literatura es la relación de la VDD con mecanismos genéticos y neurológicos. Objetivo: evaluar la relación de la VDD con la depresión gestacional y posparto. Métodos: esta revisión siguió las recomendaciones propuestas por los Elementos de Informes Preferidos para revisiones sistemáticas y metaanálisis. La investigación se llevó a cabo en bases de datos electrónicas, PubMed y LILACS, incluyendo estudios de tipo analítico (sección transversal y longitudinal), revisiones sistemáticas, metaanálisis y ensayos clínicos controlados realizados en seres humanos; se aplicaron criterios de inclusión y exclusión. Resultados y conclusiones: en esta revisión sistemática se analizaron ocho artículos que comprenden a 8716 mujeres de siete países diferentes. Entre los artículos seleccionados, seis encontraron asociación entre la VDD y la depresión gestacional y posparto. Teniendo en cuenta la recopilación de datos, fue posible concluir que existe una relación probable entre la VDD y una mayor predisposición a la depresión gestacional y posparto. También llegamos a la conclusión de que la suplementación con vitamina D ha demostrado ser una estrategia prometedora para reducir el riesgo de síntomas depresivos.


Asunto(s)
Depresión Posparto/etiología , Depresión/etiología , Complicaciones del Embarazo/etiología , Deficiencia de Vitamina D/complicaciones , Adulto , Calcitriol/metabolismo , Depresión Posparto/sangre , Depresión Posparto/prevención & control , Femenino , Predisposición Genética a la Enfermedad , Humanos , Embarazo , Complicaciones del Embarazo/sangre , Receptores de Calcitriol/genética , Vitamina D/administración & dosificación , Deficiencia de Vitamina D/genética , Vitaminas/administración & dosificación
5.
J Ethnopharmacol ; 235: 1-7, 2019 May 10.
Artículo en Inglés | MEDLINE | ID: mdl-30721736

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia, insulin resistance, and dyslipidemia. It has broad occurrence worldwide, affecting millions of people, and can cause serious complications. The olive (Olea europaea L.) has important pharmacological functions, including anti-inflammatory, antioxidant, and hypoglycemic activities. Olive leaves are used in traditional medicine for diabetes and hypertension. AIM OF THE STUDY: To evaluate the effect of the ethanolic extract of olive leaves (EEOL) on the metabolism of rats with diabetes induced by a high-fat diet and low dose of streptozotocin (STZ). MATERIALS AND METHODS: Male Wistar rats were either given normal feed or a high-fat diet (70% standard laboratory feed, 15% sucrose, 10% lard and 5% yolk powder) for four weeks, followed by administration of STZ (35 mg/kg, via ip). Animals with fasting glucose levels above 200 mg/dL were considered diabetic. Animals were divided into 5 groups, which received ethanol (10 mL/kg), metformin (250 mg/kg), or EEOL at doses of 200 and 400 mg/kg during 10 weeks by oral gavage. Blood samples were used to measure hematological and biochemical parameters, and kidneys were removed for posterior analysis. Body weight was recorded weekly. RESULTS: A significant decrease in body weight was observed among diabetic animals treated with ethanol and EEOL compared to the control group. Moreover, animals treated with EEOL showed an improvement in glucose levels and in levels of inflammatory and metabolic markers when compared to diabetic animals. CONCLUSIONS: The results indicate a potential anti-diabetic activity of olive leaves, however more studies are needed to validate clinical effects.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Olea/química , Extractos Vegetales/farmacología , Animales , Glucemia/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Dieta Alta en Grasa , Relación Dosis-Respuesta a Droga , Etanol/química , Hipoglucemiantes/administración & dosificación , Hipoglucemiantes/aislamiento & purificación , Masculino , Medicina Tradicional/métodos , Extractos Vegetales/administración & dosificación , Hojas de la Planta , Ratas , Ratas Wistar , Estreptozocina
6.
Biomed J ; 41(3): 194-201, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-30080659

RESUMEN

BACKGROUND: The present study aimed to evaluate the possible acute oral toxicity of Baccharistrimera leaf dye as well as its antimicrobial activity. METHOD: Organization for Economic co-operation and development (OECD) 423 was used to assess acute oral toxicity and as per protocol a dose of 2000 mg/kg of tincture was administered to Wistar rats, male and female, and observed for 14 days. Biochemical and hematological analyzes were performed with sample collected of rat. The dye was evaluated for antimicrobial activity by agar diffusion and microdilution methods, which allow to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) and antibiofilm potential. RESULTS: The results showed that there was no loss of animals and no significant changes in hematological and biochemical parameters after oral administration of 2000 mg/kg of tincture and was considered safe by the OECD, classified as category 5. The dyeing also showed an important antimicrobial activity against gram positive and gram negative bacteria also significantly decreased the microbial biofilm. CONCLUSION: The tincture of B.trimera leaf when given orally once can be considered safe and has a relevant antimicrobial potential that should be elucidated in subsequent research.


Asunto(s)
Antiinfecciosos/farmacología , Baccharis/toxicidad , Extractos Vegetales/toxicidad , Animales , Biopelículas/efectos de los fármacos , Femenino , Masculino , Pruebas de Sensibilidad Microbiana , Extractos Vegetales/farmacología , Hojas de la Planta , Ratas , Ratas Wistar , Pruebas de Toxicidad Aguda
7.
Nutrients ; 10(2)2018 Jan 30.
Artículo en Inglés | MEDLINE | ID: mdl-29385682

RESUMEN

Considering the inadequacy of some antioxidant nutrients in severely obese adolescents, this study aimed to assess the relationship between antioxidant micronutrients status and metabolic syndrome components in metabolically healthy obesity (MHO) and unhealthy obesity (MUO). We performed an observational study in severely obese adolescents (body mass index > 99th percentile) and they were classified into MHO or MUO, according to the criteria adapted for adolescents. Anthropometric, biochemical, and clinical variables were analyzed to characterize the sample of adolescents. The serum antioxidant nutrients assessed were retinol, ß-carotene, Vitamin E, Vitamin C, zinc and selenium. A total of 60 adolescents aged 17.31 ± 1.34 years were enrolled. MHO was identified in 23.3% of adolescents. The MHO group showed lower frequency of non-alcoholic fatty liver disease (14.3% vs. 78.3%, p < 0.001) when compared to MUO. A correlation was found between retinol and ß-carotene concentrations with glycemia (r = -0.372; p = 0.011 and r = -0.314; p = 0.034, respectively) and between Vitamin E with waist circumference (r = -0.306; p = 0.038) in the MUO group. The current study shows that some antioxidant nutrients status, specifically retinol, ß-carotene, and Vitamin E, are negatively associated with metabolic alterations in MUO. Further studies are necessary to determine the existing differences in the serum antioxidant profile of metabolically healthy and unhealthy obese adolescents.


Asunto(s)
Fenómenos Fisiológicos Nutricionales de los Adolescentes , Estado Nutricional , Obesidad Metabólica Benigna/metabolismo , Obesidad Mórbida/metabolismo , Estrés Oxidativo , Obesidad Infantil/metabolismo , Adolescente , Índice de Masa Corporal , Brasil/epidemiología , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/etiología , Femenino , Humanos , Masculino , Síndrome Metabólico/epidemiología , Síndrome Metabólico/etiología , Enfermedad del Hígado Graso no Alcohólico/epidemiología , Enfermedad del Hígado Graso no Alcohólico/etiología , Obesidad Metabólica Benigna/sangre , Obesidad Metabólica Benigna/fisiopatología , Obesidad Mórbida/sangre , Obesidad Mórbida/fisiopatología , Obesidad Infantil/sangre , Obesidad Infantil/fisiopatología , Prevalencia , Factores de Riesgo , Selenio/sangre , Índice de Severidad de la Enfermedad , Vitaminas/sangre , Circunferencia de la Cintura , Zinc/sangre
8.
J Bras Nefrol ; 36(4): 451-9, 2014.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-25517273

RESUMEN

INTRODUCTION: The lower urinary tract dysfunction (LUTD) corresponds to changes in the filling or emptying of urine caused by neurogenic, anatomical and functional alterations. OBJECTIVE: To evaluate the impact of treatment in children and adolescents with LUTD. METHODS: Historical cohort of 15 year follow-up with the participation of 192 patients (123F, 69M), aged 0.1 to 16.8 years, analyzed at admission (T0) and at final follow-up (T1). Most patients belong to a neurologic bladder dysfunction group (60.4%). The treatment was uroterapy with behavioral and cognitive intervention, timed voiding, oral hydration, laxative diet, biofeedback, sacral nerve stimulation, clean intermittent catheterization (CIC), anticholinergic therapy, rectal enema, treatment of urinary tract infection (UTI) and, in refractory cases, surgical procedures such as continent and incontinent urinary diversion (vesicostomy), bladder augmentation and conduit for performing antegrade colonic enema. RESULTS: The main symptoms were daytime urinary incontinence (82.3%), the non-monosymptomatic nocturnal enuresis (78.6%), fecal incontinence (54.2%) and constipation (47.9%). There was a significant reduction of urinary tract infection (p = 0.0027), daytime urinary incontinence (p < 0.001), nocturnal enuresis (p < 0.001), fecal incontinence (p = 0.010) and of vesicoureteral reflux (p = 0.01). There was significant increase in the use of CIC (p = 0.021), of anticholinergic therapy (p < 0.001) and decrease of chemoprophylaxis (p < 0.001). CONCLUSION: This study showed that treatment of LUTD in children must be individualized, and requires constant monitoring of clinical, laboratory and imaging to minimize the risk of kidney damage.


Asunto(s)
Síntomas del Sistema Urinario Inferior/terapia , Grupo de Atención al Paciente , Adolescente , Niño , Preescolar , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Lactante , Estudios Longitudinales , Masculino , Estudios Retrospectivos , Encuestas y Cuestionarios
9.
J. bras. nefrol ; 36(4): 451-459, Oct-Dec/2014. tab
Artículo en Portugués | LILACS | ID: lil-731144

RESUMEN

Introdução: A disfunção do trato urinário inferior (DTUI) corresponde a alterações no enchimento ou esvaziamento de urina de causas neurogênicas, anatômicas e funcionais. Objetivo: Avaliar o impacto do tratamento em crianças e adolescentes com DTUI. Métodos: Coorte histórica de 15 anos de seguimento com participação de 192 pacientes (123F, 69M) com idade inicial de 0,1 a 16,8 anos, analisados à admissão (T0) e ao final do seguimento (T1). A maioria dos pacientes era do grupo neurológico (60,4%). O tratamento instituído foi a uroterapia com intervenção comportamental e cognitiva, micção de hora marcada, hidratação oral, dieta laxativa, biofeedback, eletroestimulação sacral, cateterismo vesical intermitente limpo (CIL), terapia anticolinérgica, enema retal, tratamento da infecção do trato urinário (ITU) e, nos casos refratários, procedimentos cirúrgicos, tais como a derivação urinária continente e incontinente (vesicostomia), ampliação vesical e conduto para a realização do enema anterógrado cólico. Resultados: Os principais sintomas foram incontinência urinária diurna (82,3%), enurese noturna não monossintomática (78,6%), incontinência fecal (54,2%) e constipação intestinal (47,9%). Detectou-se redução significativa da infecção do trato urinário (p = 0,0027), da incontinência urinária diurna (p < 0,001), da enurese noturna (p < 0,001), da incontinência fecal (p = 0,010) e do refluxo vesicoureteral (p = 0,01). Houve aumento significativo no uso do CIL (p = 0,021), da terapia com anticolinérgico (p < 0,001) e diminuição da quimioprofilaxia (p < 0,001). Conclusão: Este estudo mostrou que o tratamento da DTUI na criança ...


Introduction: The lower urinary tract dysfunction (LUTD) corresponds to changes in the filling or emptying of urine caused by neurogenic, anatomical and functional alterations. Objective: To evaluate the impact of treatment in children and adolescents with LUTD. Methods: Historical cohort of 15 year follow-up with the participation of 192 patients (123F, 69M), aged 0.1 to 16.8 years, analyzed at admission (T0) and at final follow-up (T1). Most patients belong to a neurologic bladder dysfunction group (60.4%). The treatment was uroterapy with behavioral and cognitive intervention, timed voiding, oral hydration, laxative diet, biofeedback, sacral nerve stimulation, clean intermittent catheterization (CIC), anticholinergic therapy, rectal enema, treatment of urinary tract infection (UTI) and, in refractory cases, surgical procedures such as continent and incontinent urinary diversion (vesicostomy), bladder augmentation and conduit for performing antegrade colonic enema. Results: The main symptoms were daytime urinary incontinence (82.3%), the non-monosymptomatic nocturnal enuresis (78.6%), fecal incontinence (54.2%) and constipation (47.9%). There was a significant reduction of urinary tract infection (p = 0.0027), daytime urinary incontinence (p < 0.001), nocturnal enuresis (p < 0.001), fecal incontinence (p = 0.010) and of vesicoureteral reflux (p = 0.01). There was significant increase in the use of CIC (p = 0.021), of anticholinergic therapy (p < 0.001) and decrease of chemoprophylaxis (p < 0.001). Conclusion: This study showed that treatment of LUTD in children must be individualized, and requires constant monitoring of clinical, laboratory and imaging to minimize the risk of kidney damage. .


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Grupo de Atención al Paciente , Síntomas del Sistema Urinario Inferior/terapia , Encuestas y Cuestionarios , Estudios Retrospectivos , Estudios de Cohortes , Estudios de Seguimiento , Estudios Longitudinales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA